The analysis of biomarkers in biological fluids (liquid biopsies) shows great potential for diagnosing complex diseases like cancer with high sensitivity and minimal invasiveness. Most studies have focused on cfDNA, but cfRNA is gaining traction despite challenges in reproducibility, standardization, and cohort size. This review addresses these challenges and proposes solutions.

read more